The Effect of Pre-operative Single Dose Antibiotic Prophylaxis on the Post-operative Implant Success
Launched by BIRUNI UNIVERSITY · Apr 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving a single dose of antibiotics before dental implant surgery can help improve the success of the implant and reduce complications after the procedure. Researchers are looking at how well the implant works and how stable it is after surgery in 50 participants. Half of the participants will receive the antibiotic amoxicillin combined with clavulanic acid, while the other half will receive a placebo, which does not contain any active medication.
To be eligible for this trial, participants should be experiencing tooth loss. However, individuals with certain health conditions, such as systemic diseases, or those who are pregnant or breastfeeding, cannot participate. If you join the study, you can expect to be closely monitored after your surgery for any complications or issues with the implant. This trial is important because it aims to provide more clarity on the role of antibiotics in dental implant procedures, which is still a topic of debate among dental professionals.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Tooth loss
- Exclusion Criteria:
- • Systemic disease
- • Lactation/pregnancy
About Biruni University
Biruni University is a leading academic institution dedicated to advancing healthcare through innovative research and education. With a strong emphasis on clinical trials, the university collaborates with multidisciplinary teams to conduct rigorous studies that contribute to medical knowledge and improve patient outcomes. Leveraging state-of-the-art facilities and a commitment to ethical research practices, Biruni University aims to foster scientific discovery and translate findings into practical applications in the healthcare field. Through its clinical trial initiatives, the university plays a pivotal role in shaping the future of medicine and enhancing community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Mustafa Yılmaz, PhD
Principal Investigator
Biruni University, assistant professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials